Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities

ABSTRACTCombination antiretroviral therapy (cART) is effective but not curative, and no successful vaccine is currently available for human immunodeficiency virus-1 (HIV-1). Broadly neutralizing antibodies (bNAbs) provide a new approach to HIV-1 prevention and treatment, and these promising candidat...

Full description

Bibliographic Details
Main Authors: Yubin Liu, Wei Cao, Ming Sun, Taisheng Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
HIV-1
broadly neutralizing antibodies (bNAbs)
efficacies
challenges
opportunities
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1713707

Similar Items

Similar Items